SITC 2023: Cell Therapy Post-Conference Report

The 2023 SITC Annual Congress was held from 1st – 5th November in San Diego, CA. Our analyst team have screened the abstracts presented and identified 154 abstracts (50 clinical and 104 preclinical) associated with trial or drug records on Beacon Cell Therapy. This remains consistent with the 154 relevant cell therapy abstracts presented at SITC last year.

The majority (68%) of abstracts presented contained preclinical drug data, while 26% showcased clinical trial data and a further 6% of abstracts outlined trial protocols.

Get ready to make the most out of the conference with our Post Conference Cell Therapy Report.

SITC 2023: Cell Therapy Abstract Highlights

This report provides a comprehensive guide to cell therapy abstracts presented at the conference. It includes an analysis of these abstracts, focusing on the distribution of therapeutic class, target, starting material, and trial phase. Additionally, it provides a summary breakdown of the abstracts.

We hope you find this report useful and insightful and are as excited as we are to see the latest developments in the cell therapy field.

Download Report

You May Also Be Interested In…

AACR 2025: RNA Pre-Conference Planner

Access Report

AACR 2025: Cell Therapy Pre-Conference Planner

Access Report

AACR 2025: ADC Pre-Conference Planner

Access Report

View All

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more